Skip to content
All Brands

J&J INNOVATIVE MEDICINE

1 recall on record · Last recall: Sep 23, 2026

Read the history in context

Records, not a safety rating.

Recall counts do not account for sales volume, exposure or differences in reporting. Agency records can overlap. A low count does not establish that a brand or product is safe.

View source coverage →

Severity Breakdown

Class I — Serious
0
Class II — Moderate
1
Class III — Low Risk
0

Categories

MEDICATION

Recall Timeline

Class IIFDASep 23, 2026

J&J INNOVATIVE MEDICINE — Presence of particulate matter.

IMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, For Intravenous Infusion After Dilution, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044. NDC: 57894-800-01 Presence of particulate matter.

Track J&J INNOVATIVE MEDICINE recalls automatically

Get an alert when a matching J&J INNOVATIVE MEDICINE recall turns up.

Start Free Trial